NAMRATA KUMAR: Open Payments
NPI 1407910896 · ELYRIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,470 in 94 payments from 18 companies in 2025. Trend: 2023 $2,350 · 2024 $2,618 · 2025 $2,470
Food & beverage: $2,419Education: $51
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 14 | $596 |
| Xeris Pharmaceuticals, Inc. | 16 | $349 |
| Ascendis Pharma Endocrinology Inc | 12 | $344 |
| Novo Nordisk Inc | 12 | $240 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $236 |
| Corcept Therapeutics | 9 | $172 |
| Inspire Medical Systems, Inc. | 2 | $115 |
| Amneal Pharmaceuticals LLC | 3 | $73 |
| Madrigal Pharmaceuticals | 3 | $68 |
| Dexcom, Inc. | 2 | $48 |
Products named: AFREZZA, Yorvipath, ISTURISA, RECORLEV, Ozempic, Korlym, GVOKE HYPOPEN, INSPIRE.
Industry payments across OH — which companies pay providers there.
